Effect of Sildenafil on the clinical course of newborns with transient tachypnea of newborns

Effect of Sildenafil on the clinical course of newborns with transient tachypnea of newborns, A Clinical Trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20161206031269N2

Enrollment

Registered

2018-09-03

Start date

2018-02-20

Completion date

Unknown

Last updated

2018-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Newborns with transient tachypnea of newborns. Transient tachypnea of newborns (TTN)

Interventions

Intervention 1: Intervention group: In the intervention group, sildenafil was given as mg / kg 1 every 8 hours with a gavage tube, the first dose was administered immediately after admission. Interven

Eligibility

Sex/Gender

All

Age

238 Days to 287 Years

Inclusion criteria

Inclusion criteria: Newborns with transient tachypnea of newborns

Exclusion criteria

Exclusion criteria: Moconia aspiration Raspiratory distress syndrom Pneumonia Congenital heart disease Sustained hypoglycemia Polycytemia Congenital anomaly Proven systemic infection Intrauterine growth retardation Fetal distress Multiple organ dysfunction score Poisonous hypoxia

Design outcomes

Primary

Measure	Time frame
The need for mechanical ventilation. Timepoint: Start of intervention and discharge time. Method of measurement: Based on clinical symptoms.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Masoud Dehdashtian

Ahvaz University of Medical Sciences

dehdashtian@ajums.ac.ir+98 61 1333 5935

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026